I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
By Khalid El Bairi, MDOn a beautiful morning in early October 2022, I received a WhatsApp message from an enthusiastic young professor of pharmacy, Dr. Faisal Gulzar, who invited me to deliver presentations in a country very far from my home in Morocco—Pakistan! A country that I've never visited and that I mostly know...
New Trials in Colorectal Cancer: Could Your Patient Benefit?
Perhaps one of your patients could benefit from joining a clinical trial currently recruiting people with colorectal cancer. Medscape Medical News
Colorectal Cancer Incidence Doubled in Younger Adults
Colorectal cancer has increased rapidly among people younger than 55, and the incidence of more advanced disease has increased in all age groups, notes a new report from the American Cancer Society. Medscape Medical News
The Psychological Toll of Surviving Colorectal Cancer
The worst long-term recollection among colorectal cancer survivors was 'psychological distress,' a new survey-based study found. Medscape Medical News
Colorectal Cancer Treatment Outcomes in Older Adults
Two new studies report results with adjuvant chemotherapy in older patients with stage 3 colorectal cancer; those who can tolerate it have better outcomes. MDedge News
New Treatment Recommendations for Early-Onset CRC
An international group of physicians has issued a list of 31 treatment recommendations for patients diagnosed with early-onset colorectal cancer (before 50 years of age). MDedge News
Does Appendectomy Raise the Risk for Colorectal Cancer?
A small study suggests that appendectomy may contribute to colorectal cancer risk by altering the gut microbiome, but experts urge caution in interpreting the findings. Medscape Medical News
Tucatinib Plus Trastuzumab Approved for HER2+ CRC
The combination of HER2-targeted agents is already approved for use in breast cancer and is now is the first treatment approved for HER2-positive colorectal cancer. FDA Approvals
New Standard of Care for Early dMMR/MSI-H Colorectal Cancer?
Another study shows good results with neoadjuvant immunotherapy in patients with locally advanced dMMR/MSI-H colorectal cancer, leading the authors to suggest it as a new standard of care. Medscape Medical News
Test Predicts Which CRC Patients Benefit from Adjuvant Chemo
Testing for molecular residual disease was able to identify patients with early-stage colorectal cancer who are most likely to benefit from adjuvant chemotherapy. Medscape Medical News
